Nanobody-based individualized AXL targeting to reverse immune suppression and overcome therapy resistance in Acute Myeloid Leukemia

Vandewalle, Niels (Administrative Promotor)
De Veirman, Kim (Administrative Promotor)

Basic (bio-) Medical Sciences

1 Scientific review

1 results

2024

AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies
Vandewalle, N., De Beule, N., De Becker, A., De Bruyne, E., Menu, E., Vanderkerken, K., Breckpot, K., Devoogdt, N. & De Veirman, K., Dec 2024, In: Experimental Hematology and Oncology. 13, 1, 20 p., 99.
Research output: Contribution to journal › Scientific review › peer-review

Open Access
File

12 Downloads (Pure)